Delivery Order SPE2DB20D2104-SPE2DB22FU09K
Award Date 9/28/22
Potential Completion Date 9/29/22
Potential Value $15K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The $4,529.50 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 26, 2025 and was awarded on February 25, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- This federal contract award is for the delivery of RESTASIS 0.05% Eye Emulsion to the Defense Logistics Agency (DLA). The $3,519 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 23, 2022 and was awarded on August 22, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,080.48 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on July 21, 2022. The contract has an ultimate completion date of July 22, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a large $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,446.44 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 22, 2022 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, a subsidiary of the parent company...
- This federal contract award is for the supply of RESTASIS 0.05% EYE EMULSION 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,299.77 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion, a specialty ophthalmic medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,499.40 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 27, 2022 with a completion date of June 28, 2022. This award is a child contract under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The fixed-price delivery order, valued at $4,356.93, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price totaling $2,389.44 and a completion date of November 17, 2022. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion 30s to the Defense Logistics Agency (DLA). The $15,793.32 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 29, 2022. The contract has an ultimate completion date of December 30, 2022 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award is for the delivery of RESTASIS 0.05% eye emulsion 30s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $56,634.35. The contract has a firm fixed-price pricing type and an ultimate completion date of November 20, 2024. The contract is a delivery order without any set-aside designation, indicating open competition. It...